Fractyl Health (GUTS) Competitors $1.01 +0.03 (+2.65%) Closing price 04:00 PM EasternExtended Trading$1.01 +0.00 (+0.50%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GUTS vs. KRMD, CV, INFU, INGN, PROF, ELMD, PDEX, LNSR, TLSI, and LAKEShould you be buying Fractyl Health stock or one of its competitors? The main competitors of Fractyl Health include KORU Medical Systems (KRMD), CapsoVision (CV), InfuSystem (INFU), Inogen (INGN), Profound Medical (PROF), Electromed (ELMD), Pro-Dex (PDEX), LENSAR (LNSR), TriSalus Life Sciences (TLSI), and Lakeland Industries (LAKE). These companies are all part of the "medical equipment" industry. Fractyl Health vs. Its Competitors KORU Medical Systems CapsoVision InfuSystem Inogen Profound Medical Electromed Pro-Dex LENSAR TriSalus Life Sciences Lakeland Industries KORU Medical Systems (NASDAQ:KRMD) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, profitability, valuation and earnings. Do analysts prefer KRMD or GUTS? KORU Medical Systems currently has a consensus target price of $4.63, suggesting a potential upside of 7.56%. Fractyl Health has a consensus target price of $11.00, suggesting a potential upside of 989.11%. Given Fractyl Health's higher possible upside, analysts plainly believe Fractyl Health is more favorable than KORU Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KORU Medical Systems 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00Fractyl Health 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, KRMD or GUTS? KORU Medical Systems has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Comparatively, Fractyl Health has a beta of 1.66, meaning that its stock price is 66% more volatile than the S&P 500. Does the media prefer KRMD or GUTS? In the previous week, Fractyl Health had 4 more articles in the media than KORU Medical Systems. MarketBeat recorded 10 mentions for Fractyl Health and 6 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 0.77 beat Fractyl Health's score of 0.13 indicating that KORU Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fractyl Health 1 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable earnings and valuation, KRMD or GUTS? KORU Medical Systems has higher revenue and earnings than Fractyl Health. KORU Medical Systems is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKORU Medical Systems$33.65M5.91-$6.07M-$0.09-47.78Fractyl Health$90K549.66-$68.69M-$1.85-0.55 Is KRMD or GUTS more profitable? KORU Medical Systems has a net margin of -12.24% compared to Fractyl Health's net margin of -73,864.52%. KORU Medical Systems' return on equity of -26.77% beat Fractyl Health's return on equity.Company Net Margins Return on Equity Return on Assets KORU Medical Systems-12.24% -26.77% -16.81% Fractyl Health -73,864.52%-344.49%-92.20% Do insiders and institutionals hold more shares of KRMD or GUTS? 58.6% of KORU Medical Systems shares are held by institutional investors. 20.6% of KORU Medical Systems shares are held by company insiders. Comparatively, 27.0% of Fractyl Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryKORU Medical Systems beats Fractyl Health on 10 of the 16 factors compared between the two stocks. Get Fractyl Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GUTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GUTS vs. The Competition Export to ExcelMetricFractyl HealthMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$48.19M$2.44B$5.55B$9.83BDividend YieldN/A1.78%4.62%4.11%P/E Ratio-0.4922.3830.1526.03Price / Sales549.66725.14460.84104.94Price / CashN/A183.0237.7558.93Price / Book1.714.708.476.06Net Income-$68.69M$31.61M$3.26B$265.11M7 Day PerformanceN/A2.95%3.56%2.90%1 Month Performance-33.55%4.27%5.97%3.99%1 Year Performance-56.09%7.66%42.70%26.92% Fractyl Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GUTSFractyl Health2.4674 of 5 stars$1.01+2.7%$11.00+989.1%-51.8%$48.19M$90K-0.49102News CoverageEarnings ReportKRMDKORU Medical Systems1.1799 of 5 stars$4.04+2.0%$4.63+14.5%+68.7%$183.09M$33.65M-44.8980Earnings ReportCVCapsoVisionN/A$4.11+4.6%$5.50+33.8%N/A$182.13MN/A0.0090News CoverageQuiet Period ExpirationGap DownINFUInfuSystem3.0786 of 5 stars$8.60-2.6%$12.50+45.3%N/A$175.66M$139.89M143.36410High Trading VolumeINGNInogen4.001 of 5 stars$7.04+8.6%$11.00+56.3%-35.7%$174.23M$335.70M-6.641,030News CoverageEarnings ReportPROFProfound Medical2.4919 of 5 stars$5.63+1.6%$11.00+95.4%-35.9%$166.49M$10.68M-4.61150News CoverageELMDElectromed1.784 of 5 stars$19.15+2.7%$33.50+74.9%+33.4%$160.59M$61.44M25.53160PDEXPro-Dex3.1523 of 5 stars$38.41-19.6%$56.00+45.8%+109.5%$155.71M$53.84M13.72140Positive NewsHigh Trading VolumeLNSRLENSAR0.6168 of 5 stars$13.03+1.2%$15.00+15.1%+222.2%$151.76M$53.49M-3.10110Negative NewsEarnings ReportUpcoming EarningsTLSITriSalus Life Sciences2.718 of 5 stars$3.57-9.6%$10.75+201.1%-37.5%$149.46M$29.43M-3.19106News CoverageEarnings ReportGap UpLAKELakeland Industries4.7904 of 5 stars$13.76-2.6%$26.00+89.0%-38.9%$134.44M$167.21M-4.572,100Positive News Related Companies and Tools Related Companies KORU Medical Systems Alternatives CapsoVision Alternatives InfuSystem Alternatives Inogen Alternatives Profound Medical Alternatives Electromed Alternatives Pro-Dex Alternatives LENSAR Alternatives TriSalus Life Sciences Alternatives Lakeland Industries Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GUTS) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fractyl Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fractyl Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access